Skip to content
healthcare.dev
Get a free key

Fabrazyme

NDC 58468-0041, AGALSIDASE BETA, injection, powder, lyophilized, for solution, from Genzyme Corporation.

Product NDC
58468-0041
Status
Listed
Labeler
Genzyme Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103979
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AGALSIDASE BETA5 mg/mL

Pharmacologic classes

Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
58468-0041-1584680041011 VIAL, GLASS in 1 CARTON (58468-0041-1) / 1 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/988513ab-b06f-4dd0-93f7-d2d4531dcce4

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58468-0041

Use it

Look up 58468-0041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.